News

Tornado Rips Through North Carolina Pfizer Site, Damaging Drug Supplies

A tornado caused extensive damage to a Pfizer drug manufacturing site in Rocky Mount, N.C., on Wednesday, threatening critical supplies for hospitals across the country. The company estimated that one-fourth of the injectable medications it supplies to U.S. hospitals were made at the Rocky Mount property, including drugs used during surgeries and other procedures to

READ MORE
News

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, and Medicare said it would cover much of its high cost, laying the foundation for widespread use of a medication that can modestly slow cognitive decline in the early stages of the disease but also carries significant safety risks. The

READ MORE
News

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

The drug manufacturer Eli Lilly announced on Wednesday that a clinical trial of an experimental Alzheimer’s drug showed it can slow progress of the feared disease and allow patients to have more time when they can still live independently, performing tasks like cooking meals, going to the store and driving a car. Lilly announced its

READ MORE
News

Scientists Query Information Behind an Experimental Alzheimer’s Drug

“There’s simply no risk, no rational means this might occur,” he stated. Elisabeth Bik, a leading expert in picture manipulation, turned conscious of the corporate final summer season after brief sellers filed the F.D.A. petition. In a collection of twitter posts, posts on her weblog and on the web site PubPeer, Dr. Bik has pointed

READ MORE